Evidence map›Paper›PMID 30441875›Full record

ArticleInternational journal of environmental research and public health2018

Correlates of Transitions in Tobacco Product Use by U.S. Adult Tobacco Users between 2013⁻2014 and 2014⁻2015: Findings from the PATH Study Wave 1 and Wave 2.

Karin A Kasza, Blair Coleman, Eva Sharma, Kevin P Conway, K Michael Cummings, Maciej L Goniewicz, Raymond S Niaura, Elizabeth Y Lambert, Liane M Schneller, Shari P Feirman and 14 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Sex Differences in E-Cigarette Use and Related Health Effects.International journal of environmental research and public health · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 2 countries.

Karin A KaszaDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. karin.kasza@roswellpark.org.
Blair ColemanOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Blair.Coleman@fda.hhs.gov.
Eva SharmaWestat, Rockville, MD 20850, USA. EvaSharma@westat.com.
Kevin P ConwayNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, USA. kconway@rti.org.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA. cummingk@musc.edu.
Maciej L GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Maciej.Goniewicz@RoswellPark.org.ORCID 0000-0001-6748-3068
Raymond S NiauraThe Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC 20001, USA. niaura@nyu.edu.
Elizabeth Y LambertNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, USA. elambert@nida.nih.gov.
Liane M SchnellerDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Liane.Schneller@RoswellPark.org.
Shari P FeirmanOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Shari.Feirman@fda.hhs.gov.
Elisabeth A DonaldsonOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Elisabeth.Sherman@fda.hhs.gov.
Yu-Ching ChengOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Yu-Ching.Cheng@fda.hhs.gov.
Iilun MurphyOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Iilun.Murphy@fda.hhs.gov.
Jennifer L PearsonThe Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC 20001, USA. jennipearson@unr.edu.
Dennis R TrinidadDepartment of Family Medicine and Public Health, University of California, La Jolla, CA 92093, USA. dtrinidad@ucsd.edu.
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Maansi.Travers@RoswellPark.org.
Tara Elton-MarshallInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, London, ON M5T 1R8, Canada. Tara.EltonMarshall@camh.ca.
Daniel A GundersenDepartment of Family Medicine and Community Health, Robert Wood Johnson Medical School, Rutgers, Somerset, NJ 08873, USA. DanielA_Gundersen@dfci.harvard.edu.
Cassandra A StantonWestat, Rockville, MD 20850, USA. CassandraStanton@westat.com.
David B AbramsThe Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC 20001, USA. david.b.abrams@nyu.edu.
Geoffrey T FongSchool of Public Health and Health Systems, University of Waterloo, Waterloo, ON N2L 3G1, Canada. geoffrey.fong@uwaterloo.ca.
Nicolette BorekOffice of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Nicolette.Borek@fda.hhs.gov.
Wilson M ComptonNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, USA. wcompton@nida.nih.gov.
Andrew J HylandDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Andrew.Hyland@RoswellPark.org.
United States Food and Drug Administration · USRoswell Park Comprehensive Cancer Center · USAmerican Legacy Foundation · USNational Institutes of Health · USWestat (United States) · USMedical University of South Carolina · USOntario Institute for Cancer Research · CARutgers, The State University of New Jersey · USUniversity of California San Diego · USWestern University · CA

Funding

Intramural NIH HHS Z99 MD999999NIDA NIH HHS HHSN271201100027C
6 · The paper itself

Abstract

More than half of adult tobacco users in the United States (U.S.) transitioned in tobacco product use between 2013⁻2014 and 2014⁻2015. We examine how characteristics of adult tobacco users in the U.S. relate to transitions in tobacco product use. Population Assessment of Tobacco and Health (PATH) Study data were analyzed from 12,862 adult current tobacco users who participated in Wave 1 (W1, 2013⁻2014) and Wave 2 (W2, 2014⁻2015). Three types of transitions were examined-(1) adding tobacco product(s); (2) switching to non-cigarette tobacco product(s); and (3) discontinuing all tobacco use-among those currently using: (1) any tobacco product; (2) cigarettes only (i.e., exclusive cigarette); and (3) cigarettes plus another tobacco product(s) (i.e., poly-cigarette). Multinomial logistic regression analyses determined relative risk of type of transition versus no transition as a function of demographic and tobacco use characteristics. Transitions in tobacco product use among adult tobacco users were common overall, but varied among different demographic groups, including by age, sex, sexual orientation, race/ethnicity, educational attainment, and poverty level. Further, cigarette smokers with higher dependence scores were more likely to add product(s) and less likely to discontinue tobacco use compared to those with low dependence scores. That high nicotine dependence is a barrier to discontinuing tobacco use adds evidence to support policy to lower nicotine content of cigarettes and to evaluate new products for their potential to reduce cigarette use.

Indexed as

AdolescentAdultAge FactorsElectronic Nicotine Delivery SystemsFemaleHumansMaleMiddle AgedResearch DesignSex FactorsSexualitySocioeconomic FactorsTobacco ProductsTobacco UseTobacco Use DisorderUnited Statescigarettescorrelatedemographicdependenceelectronic nicotine delivery systems (ENDS)epidemiologylongitudinalpopulationtobaccotransition

Identifiers

PMID30441875
PMCPMC6266124
OpenAlexW2901039062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.